Xometry, Inc. (NASDAQ:XMTR - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $34.89.
A number of equities research analysts have commented on the company. Citigroup reduced their target price on Xometry from $46.00 to $39.00 and set a "buy" rating for the company in a report on Thursday, February 27th. Royal Bank of Canada lifted their price objective on Xometry from $32.00 to $36.00 and gave the stock a "sector perform" rating in a report on Wednesday, May 7th. The Goldman Sachs Group increased their price objective on shares of Xometry from $30.00 to $33.00 and gave the company a "buy" rating in a research note on Thursday, May 8th. Cantor Fitzgerald increased their price objective on shares of Xometry from $20.00 to $21.00 and gave the company an "underweight" rating in a research note on Wednesday, May 7th. Finally, JMP Securities restated a "market outperform" rating and set a $42.00 price objective on shares of Xometry in a research report on Monday, February 10th.
Get Our Latest Report on XMTR
Xometry Stock Performance
Shares of NASDAQ:XMTR traded up $0.09 during trading on Tuesday, reaching $33.49. The company had a trading volume of 388,439 shares, compared to its average volume of 599,972. Xometry has a fifty-two week low of $11.08 and a fifty-two week high of $45.33. The firm has a market capitalization of $1.68 billion, a price-to-earnings ratio of -31.89 and a beta of 0.71. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.59 and a quick ratio of 4.55. The stock's fifty day moving average price is $26.31 and its 200 day moving average price is $30.98.
Insider Activity
In other Xometry news, CFO James Miln sold 1,346 shares of the company's stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $25.13, for a total transaction of $33,824.98. Following the completion of the sale, the chief financial officer now directly owns 144,713 shares in the company, valued at $3,636,637.69. This represents a 0.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Emily Rollins sold 2,000 shares of the company's stock in a transaction dated Monday, April 7th. The stock was sold at an average price of $20.66, for a total value of $41,320.00. Following the sale, the director now owns 16,146 shares of the company's stock, valued at $333,576.36. This represents a 11.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 85,297 shares of company stock valued at $2,214,438 in the last 90 days. 9.66% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of XMTR. Vanguard Group Inc. increased its holdings in Xometry by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 4,413,337 shares of the company's stock valued at $109,980,000 after purchasing an additional 120,065 shares in the last quarter. Sylebra Capital LLC lifted its position in Xometry by 2.6% during the 1st quarter. Sylebra Capital LLC now owns 1,881,624 shares of the company's stock worth $46,890,000 after acquiring an additional 46,874 shares in the last quarter. Geode Capital Management LLC lifted its position in Xometry by 0.9% during the 4th quarter. Geode Capital Management LLC now owns 1,004,452 shares of the company's stock worth $42,861,000 after acquiring an additional 8,974 shares in the last quarter. New York State Common Retirement Fund lifted its position in Xometry by 4.4% during the 1st quarter. New York State Common Retirement Fund now owns 942,088 shares of the company's stock worth $23,477,000 after acquiring an additional 39,480 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its position in Xometry by 225.7% during the 4th quarter. Ameriprise Financial Inc. now owns 852,813 shares of the company's stock worth $36,381,000 after acquiring an additional 590,974 shares in the last quarter. 97.31% of the stock is owned by institutional investors and hedge funds.
Xometry Company Profile
(
Get Free ReportXometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
Read More

Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.